Search Results for:Vinicy Chan
A $1 billion deal would be the largest consumer IPO this year in Hong Kong, which has been focused on transforming itself into a hub for fundraising by new-economy companies
HNA is working with advisers to explore possibilities for Swissport including the sale of a majority stake in the business
The investor group considering a takeover bid for Yum China includes DCP Capital and Hillhouse.
Suzhou Kintor Pharmaceuticals Inc. and Frontier Biotechnologies are planning Hong Kong stock offerings that could each raise about $300 million.
HNA has already shed more than $17 billion of assets this year, a pace of dealmaking that reverses a multiyear acquisition spree that saddled it with one of corporate China’s biggest debt loads.
Chinese acquisitions in Europe have doubled this year to $49.2 billion, even as its dealmaking in the U.S. plunged amid tightened scrutiny.
Hillhouse funds and Taobao China Holding Ltd. are among the 10 firms that agreed to buy about $1.4 billion of stock as cornerstone investors
The group is working on a restructuring of its retail operations ahead of a possible IPO as soon as next year. Any share sale could raise at least $1 billion.
At least seven senior bankers and analysts from top-tier securities firms have quit to join biotechnology companies in the city since December.
Gold Coin employs 2,600 people and runs 19 production facilities in nine countries.